S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA

por Kuo, K, Layton, D, Lal, A, Al-Samkari, H, Bhatia, J, Kosinski, P, Tong, B, Lynch, M, Uhlig, K, Vichinsky, E
Publicado 2022

P1522: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA

por Kuo, K. H. M., Layton, D. M., Lal, A., Al-Samkari, H., Bhatia, J., Kosinski, P. A., Tong, B., Lynch, M., Uhlig, K., Vichinsky, E. P.
Publicado 2022

P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALP...

por Kuo, K, Layton, D, Al-Samkari, H, Kattamis, A, Sheth, S, Taher, A, Viprakasit, V, Chamberlain, C, Czapla, L, Gheuens, S, Lynch, M, Tong, B, Uhlig, K, Cappellini, M
Publicado 2022